AIM AIM ImmunoTech Inc

USD 0.42 0.00 0
Icon

AIM ImmunoTech Inc (AIM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.42

0.00 (0.00)%

USD 0.02B

0.08M

N/A

N/A

Icon

AIM

AIM ImmunoTech Inc (USD)
COMMON STOCK | NYE
USD 0.42
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 0.42

AIM ImmunoTech Inc (AIM) Stock Forecast

N/A

Based on the AIM ImmunoTech Inc stock forecast from 0 analysts, the average analyst target price for AIM ImmunoTech Inc is not available over the next 12 months. AIM ImmunoTech Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AIM ImmunoTech Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, AIM ImmunoTech Inc’s stock price was USD 0.42. AIM ImmunoTech Inc’s stock price has changed by +10.18% over the past week, +4.30% over the past month and -19.69% over the last year.

No recent analyst target price found for AIM ImmunoTech Inc
No recent average analyst rating found for AIM ImmunoTech Inc

Company Overview AIM ImmunoTech Inc

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecu...Read More

https://www.aimimmuno.com

2117 SW Highway 484, Ocala, FL, United States, 34473

22

January

USD

USA

Adjusted Closing Price for AIM ImmunoTech Inc (AIM)

Loading...

Unadjusted Closing Price for AIM ImmunoTech Inc (AIM)

Loading...

Share Trading Volume for AIM ImmunoTech Inc Shares

Loading...

Compare Performance of AIM ImmunoTech Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AIM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AIM ImmunoTech Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CSL
Carlisle Companies Incorporate.. 0.00 (0.00%) USD126.67B 38.30 36.68

ETFs Containing AIM

Symbol Name AIM's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About AIM ImmunoTech Inc (AIM) Stock

Stock Target Advisor's fundamental analysis for AIM ImmunoTech Inc's stock is Bearish.

Unfortunately we do not have enough data on AIM's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AIM's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on AIM's stock to indicate if its overvalued.

The last closing price of AIM's stock was USD 0.42.

The most recent market capitalization for AIM is USD 0.02B.

Unfortunately we do not have enough analyst data on AIM's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains AIM ImmunoTech Inc's stock.

As per our most recent records AIM ImmunoTech Inc has 22 Employees.

AIM ImmunoTech Inc's registered address is 2117 SW Highway 484, Ocala, FL, United States, 34473. You can get more information about it from AIM ImmunoTech Inc's website at https://www.aimimmuno.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...